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Immunolocalization of Enzymes, Binding Proteins,
and Receptors Sufficient for Retinoic Acid Synthesis
and Signaling During the Hair Cycle
Helen B. Everts1, John P. Sundberg2,3, Lloyd E. King Jr2 and David E. Ong1
Retinoic acid (RA) is essential for maintenance of most epithelial tissues. One RA biosynthesis pathway consists
of cellular retinol-binding protein (Crbp), retinol dehydrogenase (Dhrs9/eRoldh), retinal dehydrogenase 1-3
(Aldh1a1-3), and cellular RA-binding protein 2 (Crabp2). Previously, we localized Aldh1a2 and Aldh1a3 to
both epithelial and mesenchymal cells within the hair follicle throughout the hair cycle. This study expands
that observation by examining the complete pathway of RA biosynthesis and signaling via RA receptors a, b, and
g by immunohistochemistry in C57BL/6J mice wax-stripped to initiate and synchronize the cycle. This pathway
of RA biosynthesis and signaling localized to the majority of layers of the hair follicle, sebaceous gland, and
interfollicular epidermis in a hair cycle-dependent manner, suggesting that RA biosynthesis within the hair
follicle is regulated in both a spatial and temporal manner. This localization pattern also revealed insights into
epithelial–mesenchymal interactions and differentiation state differences within the RA biosynthesis and
signaling pathway, as well as novel observations on nuclear versus cytoplasmic localization of Crabp2 and RA
receptors. This complex pattern of RA biosynthesis and signaling identified by immunolocalization suggests
that endogenous RA regulates specific aspects of hair follicle growth, differentiation, and cycling.
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INTRODUCTION
Vitamin A and its derivatives (retinoids) are essential for the
development and maintenance of multiple tissues, including
skin and hair (Wolbach and Howe, 1925; Frazier and Hu,
1931). Retinoic acid (RA) is the active form of vitamin A. The
synthesis of RA from circulating retinol occurs by the action
of two enzyme families (Napoli, 1999). Retinol dehydro-
genases (Roldhs) convert retinol into retinal, whereas retinal
dehydrogenases (Raldh/Aldh1a) convert retinal into RA.
There are several classes of Roldhs but only the short-chain
dehydrogenases/reductases (SDR family), localized on the
endoplasmic reticulum, recognize and oxidize retinol bound
to cellular retinol-binding protein (Crbp, contested gene
name Rbp1) (Napoli, 1999). Because of this feature, these
Roldhs are argued to be the physiological enzymes that
produce RA for hormonal signaling, although other Roldhs
may also contribute. The SDR family member dehydrogenase
reductase 9 (Dhrs9), identified in this laboratory as eRoldh
(Rexer and Ong, 2002) (also known as hRDH-TBE, hRoDH-
E2, (Chetyrkin et al., 2001; Soref et al., 2001; Markova et al.,
2003) is present in the majority of vitamin A-sensitive
epithelial cells (Everts et al., 2005). Currently, there are three
known Raldhs (gene names Aldh1a1–3) found in mice, rat,
and human that convert retinal into RA. Aldh1a2tm1Ipc-null
mice die in utero due to defects in heart development
(Niederreither et al., 1999) and Aldh1a3tm1.1Pcn-null mice die
within 10 hours of birth due to defects in nasal development
(Dupe et al., 2003), implying that they are essential for RA
synthesis. But Aldh1a1tm1Gdu-null mice have no apparent
phenotype (Fan et al., 2003). Although analysis of Aldh1a1,
Aldh1a2, and Aldh1a3 single-, double-, and triple-null mice
revealed a redundant role for Aldh1a1 in eye morphogenesis
(Molotkov et al., 2006), Aldh1a1 may also be involved in the
catabolism of excess retinol (Fan et al., 2003; Molotkov and
Duester, 2003). Two binding proteins, Crbp and cellular RA-
binding protein type II (Crabp2), are also closely associated
with RA synthesis (Bucco et al., 1997; Napoli, 1999). Crbp
acts to chaperone retinol and retinal to retinoid metabolizing
enzymes (Ong et al., 1988; Napoli, 1999), whereas Crabp2
carries RA to the nucleus, where it shuttles RA to RA recep-
tors (Rars) and increases transcriptional efficiency (Dong
et al., 1999; Budhu and Noy, 2002; Sessler and Noy, 2005).
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Three Rars have been described (Rar a (Rara), Rar b ((Rarb),
and Rar g (Rarg)), which bind DNA and regulate transcription
of specific genes in an RA-dependent manner. The binding
of Crabp2 and Rar has only been proven for Rara, but may
also occur with Rarb and/or Rarg. In contrast to Crabp2,
Crabp1 is not directed to the nucleus on RA binding and does
not bind Rars (Dong et al., 1999; Budhu and Noy, 2002).
Crabp1 may be involved in RA catabolism, but this is still
unclear (Boylan and Gudas, 1992; Chen et al., 2003). There-
fore, it can be assumed that expression of these binding
proteins, enzymes, and receptors indicates sites of RA
synthesis and action. This assumption is supported by
similar localization patterns between defects seen in vitamin
A-deficient rat embryos and Aldh1a2- and Aldh1a3-null mice
with immunohistochemical and in situ hybridization locali-
zation patterns of enzymes and binding proteins involved
in RA synthesis (Bavik et al., 1997; Niederreither et al., 1999;
Blentic et al., 2003; Dupe et al., 2003). The expression
pattern of the complete system for RA synthesis and signaling
in the hair follicle and sebaceous gland throughout the hair
cycle has not been defined. Only individual components
of this system were examined by different laboratories and
no integrated understanding of all components has yet been
attempted to our knowledge (Siegenthaler et al., 1984; Billoni
et al., 1997; Reichrath et al., 1997; Markova et al., 2003).
Crbp, Aldh1a1, Aldh1a3, and Crabp2 were found in a screen
of genes altered by the hair cycle, but a detailed analysis of
their location was not performed (Lin et al., 2004). Similar
analysis of the complete system for RA synthesis in numerous
rat epithelial tissues implicated both epithelial and mesench-
ymal cells in the synthesis of RA, which suggests a novel
requirement for the movement of retinal between cell types
(Li et al., 2004; Everts et al., 2005).
The hair cycle proceeds through four main stages: growth
(anagen), regression (catagen), rest (telogen), and release
(exogen). Signaling between epithelial and mesenchymal
cells in the stem cell containing bulge and transiently
proliferating cell containing bulb regions regulates this cycle.
Previously, we reported that Aldh1a2 was expressed in the
bulge region during anagen and early catagen, whereas
Aldh1a3 expression alternates between the mesenchymal
dermal papilla and epithelial precortex in the bulb region
during mid-late anagen (Everts et al., 2004). This study
extends that observation and characterizes the expression of
the complete system for RA biosynthesis and signaling
including Crbp, Dhrs9, Aldh1a1, Aldh1a2, Aldh1a3, Crabp2,
Rara, Rarb, and Rarg during the hair cycle in wax-stripped
C57BL/6J mice. This complete system was expressed in
the majority of layers of the hair follicle, sebaceous gland,
and interfollicular epidermis in a hair cycle-dependent
manner. Components were not always all in the same cell
layer suggesting epithelial–mesenchymal interactions are
important in this tissue as was seen for other epithelial
tissues. In addition, in some sites expression of the RA
synthesis and signaling pathway flowed through different
stages of differentiation, with the most differentiated cells
expressing the final proteins in this pathway –nuclear Crabp2
and Rars.
RESULTS
This study characterized the cell-specific location of all
known components necessary for RA biosynthesis and
signaling in the depilation-induced hair follicle both to
obtain predictions of where endogenous RA fits into the
signaling network that regulates the hair cycle, as well as to
better understand the physiological pathway of RA biosyn-
thesis and signaling. As RA synthesis cannot be measured
directly, we are assuming that presence of enzymes, proteins,
and receptors equates to RA synthesis and signaling based on
similar assumptions made in the embryo during development
(see Introduction). In addition, RA is diffusible and can act
in either the cell where it is produced (autocrine) or in a
neighboring cell (paracrine).
RA biosynthesis enzymes, binding proteins, and receptors
localized to the stem cell niche
The bulge has been shown to contain stem cells that produce
cells for the cycling lower half of the hair follicle (Cotsarelis,
2006). In telogen samples collected immediately after
depilation (day 0), the RA biosynthesis and signaling pathway
was weak or absent, except for localization of Rarb within the
bulge and Rara just outside the bulge (Tables S1 and S2). In
the second cycle of telogen (21–30 days after depilation)
immunoreactivity (IR) of the RA biosynthesis and signaling
system within the bulge was more intense, especially for
Crabp2. During anagen I, Dhrs9, Aldh1a2, Rara, Rarb, and
Rarg localized within the bulge and Rara and Crabp2 were
localized to cells just outside the bulge (Tables S1 and S2).
IR for RA synthesis proteins was greater during anagen II
with the additional weak appearance of Aldh1a1 (Figure 1a,
d, g, m, and p, arrowhead; 1j and m, long arrow). Rarb was
localized to the cytoplasm, whereas Crabp2, Rara, and Rarg
were both cytoplasmic and nuclear-localized. This locali-
zation pattern of RA synthesis and signaling in the stem
cell niche remained relatively constant throughout anagen V,
except Aldh1a3 appeared both within the bulge and,
with greater IR, in the cells outside during anagen IIIb–V
(Table S1). During anagen VI/catagen I the IRs of Dhrs9,
Aldh1a1, Aldh1a2, Aldh1a3, Rara, Rarb, and Rarg were
reduced, whereas Crabp2 localization switched from outside
to within the outer edge of the bulge (Table S1, Figure 3a, d,
e, i, l, m, p, q and t, arrowhead). Crbp IR within the
bulge increased during anagen V then faded through
catagen. Dhrs9 and Rarb localized to the bulge through
catagen IV and then faded. Aldh1a1 and Aldh1a3 were not
seen in the bulge beyond anagen V, whereas Aldh1a2,
Crabp2, Rara, and Rarg remained in the bulge throughout
the hair cycle.
RA biosynthesis enzymes, binding proteins, and receptors
localized to both matrix and dermal papilla cells, as well as
their precursor cells
The bulb is formed in early anagen from epithelial cells that
proliferate and migrate from the bulge stem cells, which
eventually enclose the dermal papilla (Cotsarelis, 2006).
Once in the bulb, these cells are called matrix cells and
are argued to be transiently amplifying cells. During anagen
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the mesenchymal connective tissue sheath that surrounds the
bottom portion of the hair follicle proliferates and migrates
into the dermal papilla (Tobin et al., 2003). Rara localized to
the connective tissue sheath surrounding the lower hair
follicle, which peaked during anagen IIIa, dropped during
anagen VI/catagen I, and remained weak through catagen
(Figure 1m–o, data not shown). Rara and Rarg localized in the
dermal papilla throughout the hair cycle with a slight drop
during anagen VI/catagen I (Table S2, Figure 2d, h, l, and p,
arrow, Figure 3q and r). Aldh1a3 appeared in the dermal
papilla in anagen IIIb, peaked during anagen IV, dropped
during anagen VI/catagen I, then was no longer seen (Table
S2, Figure 2b, f, j, and n, arrow; Figure 3i and j). Dhrs9 was
seen in the dermal papilla from anagen I–catagen IV, peaked
during anagen I, II, and IV, then faded during catagen V
(Table S2, Figure 1a and c, Figure 2a, e, i and m, short arrow).
Crabp2 IR appeared in the dermal papilla during anagen IIIa,
peaked during anagen IV, dropped during anagen V, was
weak during catagen I–IV, then faded (S2, Figure 2c, g, k, and
o, arrow; Figure 3m and n). Crbp, Dhrs9, Aldh1a2, Rara,
Rarb, and Rarg were seen in the proliferating and migrating
keratinocytes during early anagen (S1, Figure 1a, g, m, and p,
yellow x). Crabp2 localized to the nucleus of a few of these
cells (Table S1), but only Dhrs9, Rara, Rarb, and Rarg IR were
seen in these cells once they reside in the bulb (matrix cells),
beginning in anagen II and remained present throughout
anagen (Table S2, Figure 1a, c, m, o, p, and r, arrowhead,
Figure 2a–p, arrowhead).
RA biosynthesis enzymes, binding proteins, and receptors
localized to the outer root sheath, companion layer, inner root
sheath, and hair fiber
Dhrs9, Rarb, and Rarg IR were seen in the permanent outer
root sheath (isthmus and infundibular) throughout the hair
cycle, but Crbp, Aldh1a2, Crabp2, and Rara IR were more
variable (Table S1, Figure 1a, d, g, j, m, and p). As the lower
outer root sheath forms, Dhrs9, Aldh1a2, and Rarb appeared
in a gradient with the greatest IR occurring near the bulge
and reduced IR downward as was previously reported for
Aldh1a2 (Everts et al., 2004; Table S1). This pattern remained
throughout the lifespan of these cells, but IR was less during
catagen. But Crabp2 localization within the outer root sheath
was weak or absent from anagen IIIa–IV, increased during
anagen V, became constant and strong during anagen VI/
catagen I–III, formed a gradient upward during catagen IV and
then faded (Table S1, Figure 3m–p). Crbp appeared in the
outer root sheath in a similar pattern as Crabp2, but increased
during anagen IV and remained strong through catagen VI
(Table S1, Figure 3a–d). Rara and Rarg were also present
in the outer root sheath, but localization appeared more
constant (Table S1, Figure 3q–t). Rara also localized to the
connective tissue sheath surrounding the lower hair follicle
a d g j m p
b e h k n q
c f i l o r
Figure 1. Localization of RA biosynthesis and signaling pathway in anagen II hair follicles. Localization of (a–c) Dhrs9, (d–f) Aldh1a1, (g–i) Aldh1a2,
(j–l) Crabp2, (m–o) Rara, and (p–r) Rarb in anagen II hair follicles from C57BL/6J mice that were wax-stripped to induce anagen. For a, d, g, j, m, and p,
bar¼ 25.2 mM, for b, c, e, f, h, i, k, l, n, o, q, and r, bar¼ 10.1 mM. Yellow arrowhead, bulge; yellow diamond, epidermis; yellow X, proliferating keratinocytes;
S, sebocytes; long arrow, cells outside bulge; block arrow, nuclear localization; black arrowhead, matrix; short arrow, dermal papilla.
www.jidonline.org 1595
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
with greater IR than the outer root sheath during anagen I–V
(Figure 1m–o, data not shown).
The companion layer was one of the few sites to contain
both Aldh1a2 and Aldh1a3. Aldh1a3 and Rara localized to
the companion layer as soon as this structure developed in
anagen IIIa and remained in a gradient of strong to weaker
IR as this layer differentiated upward through catagen V
(Table S3, Figure 3i–l, q–t, short arrow). Aldh1a3 and Rara
IR decreased during catagen VI–VIII and were localized more
in the isthmus. By contrast, Aldh1a2 was seen to various
degrees during anagen IIIc–catagen VIII with a gradient of
weak to stronger IR as this layer differentiated upward (Table
S3). Rarb was seen in the companion layer during anagen
IIIb–V, and catagen III in a gradient of weak to strong IR,
but this gradient was reversed and more variable during
anagen VI/catagen I–II and catagen IV–VIII. Dhrs9 and
Crabp2 localized to the companion layer with a less apparent
gradient throughout the hair cycle when this layer is present
(Table S3, Figure 3e–h, m–p, short arrow). Crbp was seen in
the companion layer more variably peaking during anagen
VI/catagen I (Table S3, Figure 3a–d, short arrow).
Dhrs9 and Aldh1a3 appeared in the inner root sheath cone
as it formed during anagen IIIa and remained strong through
anagen VI/catagen I, then reduced IR through catagen VIII
(Table S2, Figure 3e–h, i–l, yellow x). Crbp and Crabp2 were
seen in the inner root sheath from anagen IIIc–catagen IV,
peaking during anagen VI/catagen I (Table S2, Figure 3a–d,
m–p, yellow x). Rara and Rarg localized to the inner root
sheath from anagen IIIa–catagen V (Table S2, Figure 3q–t,
yellow x). This system for RA synthesis and signaling showed
a gradient with the strongest IR near the bulb and reduced IR
as these cells differentiated and moved upward. Aldh1a3 IR
was greater in the outer Henle’s layer throughout anagen
(Figure 3k, yellow arrow), whereas Crabp2 IR appeared
strongest in the inner root sheath cuticle during anagen VI/
catagen I only (Figure 3o, fat arrow).
Aldh1a3 localized to the hair fiber with a gradient of strong
IR occurring in the precortex/premedulla and reduced IR as
these cells differentiate and move upward throughout anagen
(Table S2, Figure 2b, f, j, and n and Figure 3i–l, yellow
diamond). Aldh1a3 IR was stronger in the premedulla and
medulla than precortex and cortex. Dhrs9 localized variably to
a e i m
b f j n
c g k o
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Figure 2. Localization of RA biosynthesis and signaling pathway in the bulb during anagen. Expression of (a, e, i, and m) Dhrs9, (b, f, j, and n) Aldh1a3,
(c, g, k, and o) Crabp2, and (d, h, l, and p) Rara in (a–d) anagen IIIb, (e–h) anagen IIIc, (i–l) anagen IV, and (m–p) anagen V hair follicles from C57BL/6J mice
that were wax-stripped to induce anagen. Bar¼10.1 mM. Yellow diamond, premedulla/precortex; black arrowhead, matrix; black arrow, dermal papilla.
1596 Journal of Investigative Dermatology (2007), Volume 127
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
the precortex and premedulla during anagen IIIa–IV, with a
peak during anagen IIIb, and was seen in the medulla during
anagen IIIb and anagen VI/catagen I–III (Table S2, Figures 2a, e,
i and m, and 3e–h, yellow diamond). Rara and Rarg localized
to the premedulla/precotex and hair fiber in a gradient similar
to Aldh1a3 throughout anagen (Table S2, Figure 2d, h, l and p
and Figure 3q–t, yellow diamond). Crbp localized to the
precortex during anagen V and then expanded IR to also
include the premedulla and hair fiber during anagen VI/
catagen I (Table S2, Figure 3a–d, yellow diamond). Crabp2 IR
was faint or negative in the precortex/premedulla throughout
the hair cycle, but weak and strong in the more differentiated
medulla during anagen V and anagen VI/catagen I, respectively
(Table S2, Figures 2c, g, k, o, and 3m–p, yellow diamond).
RA biosynthesis enzymes, binding proteins, and receptors
localized to the sebaceous gland primarily during early-mid
anagen
Little is known about changes within the sebaceous gland
during the hair cycle, but by observation the size of this gland
changes and is the largest during early anagen (I–IIIa) and
smallest during late anagen and early catagen (Everts HB,
unpublished observation; Paus and Foitzik, 2004). Although
sebaceous gland size does not predict activity (Thody and
Shuster, 1989), different types of cells (undifferentiated,
maturing, mature) could only be distinguished in the larger
sebaceous glands. Undifferentiated cells occur on the entire
periphery of the sebaceous gland but only the ones on the
bottom are thought to differentiate as they migrate upward
(maturing). Mature sebocytes become completely filled with
lipid, die, rupture, and release their contents into the hair canal.
Localization of the RA biosynthesis and signaling pathway
varied in the sebaceous gland during the hair cycle. Throughout
the hair cycle, Dhrs9 IR was strong in the lower, undiffer-
entiated, and early maturing sebocytes with decreased IR as
sebocytes become more differentiated (Table S3, Figure 1b, S).
This gradient was less obvious in the smaller sebaceous glands
and IR was greatest during anagen I–V. The same gradient was
also seen for Aldh1a1, Aldh1a2, Aldh1a3, cytoplasmic Rara,
Rarb, and Rarg, but their IR level changed throughout the cycle
(Table S3, Figure 1e, h, n, and q, S). Aldh1a1 first appeared
during anagen I, peaked during anagen IIIb, and disappeared
during anagen VI/catagen I. Aldh1a2 and Aldh1a3 were only
seen weakly during anagen. Rars were seen in the sebaceous
gland throughout the hair cycle, but peaked during early
anagen. In contrast, Crbp and Crabp2 IR were greater in more
differentiated maturing and mature sebocytes (Table S3, Figure
1k, S). This gradient was present throughout the hair cycle
for Crabp2, but only during anagen I–V for Crbp. In addition,
Crabp2, Rara, and Rarg were localized to the nucleus in the
more-differentiated maturing and mature sebocytes in most
stages with a peak in early anagen and a drop during anagen
VI/catagen I (Table S3, Figure 1k and n, block arrow, Figure 3p
and t). This nuclear localization was highly variable between
hair follicles in the same stage, suggesting that it is a short event
that is not always captured. Crabp2, Rara, and Rarg localized
in both the cytoplasm and nucleus, whereas Rarb was only
localized in the cytoplasm throughout the hair follicle, but was
most obvious in the sebaceous gland.
RA biosynthesis enzymes, binding proteins, and receptors were
present in the epidermis
Throughout the hair cycle, Dhrs9, Aldh1a2, Crabp2, Rara,
Rarb, and Rarg were localized to the cytoplasm of the
a d e h i l
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Figure 3. Localization of RA biosynthesis and signaling pathway in anagen VI/Catagen I hair follicles. Expression of (a–d) Crbp, (e–h) Dhrs9, (i–l) Aldh1a3,
(m–p) Crabp2, and (q–t) Rara in anagen VI/catagen I hair follicles from C57BL/6J mice that were wax-stripped to induce anagen. For a, e, i, m, and q, bar¼45.8mM,
for b–d, f–h, j–l, n–p, and r–t, bar¼10.1mM. Black arrowhead, bulge; yellow diamond, hair fiber; yellow X, IRS; skinny arrow, CL; thick arrow, IRS cuticle.
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epidermis (Table S1, Figure 1a, d, g, j, m, and p, yellow
diamond). Weak Rara and Rarg IR was seen in the nuclei
of the epidermis throughout the hair cycle, whereas Crabp2
was nuclear localized in some follicles during anagen IIIa
and catagen V. Epidermis in mouse skin is thin, but when
two layers could be distinguished Aldh1a2 was stronger in
the basal/spinous layers, whereas Crabp2 was stronger in
the granulosum/corneum layers (Table S1, Figure 1g and j,
yellow diamond). The distinction between spinous and
granulosum layers is hard to make in the mouse.
DISCUSSION
In this report, we show that all components necessary for RA
biosynthesis and signaling are present throughout the hair
follicle in a hair cycle-dependent manner (Figure 4). During
telogen, Rars predominate in the cycling portion of the hair
follicle (Figure 4a, Rars alone¼purple). During anagen RA
synthesis, enzymes and Crabp2 increased (Figure 4b and c,
yellow¼Dhrs9 and Rars, Aldh1a1-3¼orange, Crabp2¼
blue), with the whole system necessary for RA synthesis
and signaling present in several sites (Figure 4b and c, red).
There was a temporary decrease in Aldh1a2 and Rars during
anagen VI/catagen I, which was restored by catagen IV
(Figure 4d and e, pink¼Dhrs9 without Rars, orange¼
Aldh1a3). Crbp IR increased during anagen VI/catagen I
and remained intense through catagen IV (Figure 4d and e,
green). By catagen VII, Dhrs9 and Rars decreased in most of
the cycling portion of the hair follicle (Figure 4f, decrease in
yellow, pink, and purple). On the basis of the assumption
that presence of enzymes, proteins, and receptors equates to
RA synthesis and signaling (see Introduction and Results), this
localization pattern suggests that RA plays many roles in the
cycling hair follicle.
One role of endogenous RA may be to regulate the telogen
to anagen transition. During telogen, the dermal papilla sits
adjacent to the bulge, and signaling between the dermal
papilla and stem cells triggers the initiation of anagen (Stenn
and Paus, 2001; Alonso and Fuchs, 2003; Cotsarelis, 2006).
As Rara can repress transcription in the absence of RA
(Privalsky, 2004), its intense presence in the dermal papilla
and cells outside the bulge along with reduced RA synthesis
enzymes at this site during telogen suggest that RA target
genes may be repressed during telogen, then activated during
anagen when RA synthesis is predicted to occur. As RA can
act by paracrine and/or autocrine mechanisms, it is unclear
whether RA signaling is occurring in the dermal papilla, stem
cells or those cells just outside the bulge (stem cell niche), or
all three as Rars localized to all three cell types. Note that
Crabp2 is not required for RA signaling, but makes it more
efficient when RA levels are low (Dong et al., 1999; Budhu
and Noy, 2002; Sessler and Noy, 2005). Crabp2 may also
be important when RA needs to be protected from degrading
enzymes. Cytochrome p450, family 26, subfamily b, poly-
peptide 1, which degrades RA, localized to the dermis
surrounding hair follicles in the embryo (Abu-Abed et al.,
2002). If the same localization pattern also occurs in the
adult, it suggests that Crabp2 is acting to facilitate RA
signaling in the niche cells during anagen, but not the rest
a Telogen
b Anagen II
c Anagen IVe Catagen IV
f Catagen VII
d Anagen VI/catagen I
Dhrs9, Rars
Crabp2
Dhrs9, Raldhs, Crabp2,
and Rars
Rars
Raldhs (Aldh1as)
Crbps
Dhrs9
Figure 4. Localization patterns of enzymes, binding proteins, and receptors
involved in RA synthesis and signaling throughout the hair cycle. (a) During
telogen, Rars (purple alone, yellow with Dhrs9) predominate with occasional
localization of Dhrs9 (yellow when with Rars, pink alone) and Raldhs (Aldh1as,
orange), whereas Crabp2 (dark blue) localized within the bulge, sebocytes, inner
layer of the outer root sheath, and stratum granulosum/cornium. Dashed and
dotted lines on top of or along with another color indicate that both of those
proteins were present in that layer. For example, the stripes of blue and orange
in the inner layer of the outer root sheath indicate that both Crabp2 and Raldhs
were seen in this layer and the orange highlights in the epidermis indicates
that Raldhs, Dhrs9, and Rars were present in the stratum basalis/spinosum.
(b) During anagen II, localization of Dhrs9 (yellow) and Raldhs (orange dots,
dashes, and highlights) increased. Crabp2 now localized to cells outside the
bulge, whereas Crbp (green dashes) and Raldhs (orange dashes) localized within
the bulge along with Dhrs9 and Rars (yellow). In the sebaceous gland the
complete system for RA synthesis and signaling (redþ green) localized to the
cytoplasm of differentiating cells, whereas Crabp2 and Rars were localized
within their nuclei. (c) By anagen IV the complete system without Crbp (red)
localized to the dermal papilla, lower companion layer, Henle’s layer of the
inner root sheath, as well as differentiating sebocytes. In addition to Crabp2 and
Rars, Raldhs now also localized to cells outside the bulge. (d) During anagen VI/
catagen I, localization of Rars dropped in the matrix, sebocytes, and connective
tissue sheath (pink is Dhrs9 only) and localization of both Rars and Dhrs9
dropped in the dermal papilla and precortex/premedulla, whereas localization
of Crbp and Crabp2 increased throughout the lower cycling hair follicle (green
and dark blue lines, dashes, highlights, and red and green line). Crabp2 now
localized to the outer edge of the bulge along with Dhrs9 and Rars. (e) During
catagen IV, the complete system with Crbp localized to the outer root sheath
and companion layer. The whole system without Rars was seen in the bulge,
whereas Rars localized to cells outside the bulge. IR of Rars increased within
the dermal papilla and sebaceous gland. Crabp2 and Rars also localized to
differentiating sebocyte nuclei. IR of Raldhs dropped in the inner root sheath and
hair fiber. (f) By catagen VII, IR of Dhrs9 and Rars dropped in many places and
Crbp was only localized to the sebaceous gland ducts. This suggests that RA
synthesis and signaling was most active during all of anagen and early catagen.
The increase of Crbp during early catagen may also suggest an increase in retinyl
ester formation (vitamin A storage), as Crbp is also involved in this process.
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of the connective tissue sheath. In other tissues, RA regulates
vitamin D receptor, bone morphogenic protein, and wingless
related mouse mammary tumor virus (Wnt)-signaling path-
ways, which are involved in anagen initiation (Botchkarev
et al., 2001; Merrill et al., 2001; Balmer and Blomhoff, 2002;
Botchkarev and Kishimoto, 2003; Van Mater et al., 2003;
Zhuang et al., 2003; Lo Celso et al., 2004; Morris et al., 2004;
Paus and Foitzik, 2004; Shibamoto et al., 2004; Shimizu and
Morgan, 2004; Tumbar et al., 2004; Lowry et al., 2005).
During early anagen, RA may regulate the proliferation and
migration of both epithelial and mesenchymal cells during
bulb formation. The localization pattern of RA synthesis and
signaling members throughout early anagen in proliferating/
migrating keratinocytes was similar to that of various Wnt-
signaling factors, as well as the Sonic hedgehog receptor
Patched homolog1 (Reddy et al., 2001; Oro and Higgins,
2003; Reddy et al., 2004). RA can have either antagonistic or
synergistic effects on Wnt signaling (Mulholland et al., 2005).
Thus, RA may regulate Wnt signaling during epithelial cell
migration and bulb formation as we suggested from Aldh1a2
localization (Everts et al., 2004). In the connective tissue
sheath Rara may either receive epithelial cell-produced RA or
repress transcription in the absence of RA (Privalsky, 2004).
The lack of Crabp2 and potential presence of cytochrome
p450, family 26, subfamily b, polypeptide 1 (Abu-Abed et al.,
2002, see above) in these cells favors the hypothesis that Rara
represes gene expression. Future studies are needed to
examine the localization patterns of RA-degradative enzymes
and Crabp type 1 throughout the hair cycle, as well as
determine what genes are repressed by unliganded Rara.
Later in anagen, endogenous RA may regulate the
differentiation of all layers of the hair follicle. Matrix cells
are believed to differentiate into the hair fiber as well as the
inner root sheath and companion layer, which enclose and
support the hair fiber (Langbein and Schweizer, 2005, Legue
and Nicolas, 2005). This process is regulated by signaling
between the matrix cells and the mesenchymal dermal
papilla, as well as signaling within these differentiating cells
(Botchkarev and Kishimoto, 2003; Paus and Foitzik, 2004;
Cotsarelis, 2006). The presence of RA synthesis and signaling
molecules in more differentiated layers of the hair follicle,
as well as the bulb, is consistent with a role for RA in
differentiation of three of these layers. RA may be acting in an
autocrine manner in the dermal papilla during anagen IIIc
and IV as the whole system is present (Figure 4c, red), or
during other stages retinal may remain in these matrix cells as
they differentiate and move upward to be converted into RA
by Aldh1a3 later during differentiation. Alternatively, retinal
may be synthesized in the epithelial matrix cells, move to the
mesenchymal dermal papilla to form RA, which then acts
back in the epithelial matrix cell. We found a similar type
of RA biosynthesis and signaling sequence in the rat uterus
(Li et al., 2004). In addition, RA appears to act only in a
paracrine manner during eye development (Molotkov et al.,
2006). Differences in Aldh1a2 and Aldh1a3 localization
between this study and our previous report (Everts et al.,
2004) are due, in part, to the fact that we examined more hair
follicles in this report. In addition, we used a different, more
sensitive, antibody against Aldh1a3 in this study (see
Materials and Methods). Formation of these layers involves
several factors regulated by RA in other tissues, including
Wnt and bone morphogenic protein pathways, and keratins
6a and keratin 75 (also known as K6hf) (Rosenthal et al.,
1992; Millar et al., 1999; Balmer and Blomhoff, 2002;
DasGupta et al., 2002; Li et al., 2003; Paus and Foitzik, 2004;
Smyth et al., 2004; Baron et al., 2005). In addition, Aldh1a3
expression in the hair fiber medulla was reduced in
dominant-negative fibroblast growth factor 7 and fibroblast
growth factor 10 receptor Fgfr2 mice (Schlake, 2005), further
supporting a role for RA in hair medulla differentiation.
In contrast to the differentiation of the companion layer,
inner root sheath, and hair fiber, recent data suggest that the
outer root sheath develops during each cycle by differentia-
tion directly from the bulge stem cells and scattered apoptosis
(Langbein and Schweizer, 2005; Legue and Nicolas, 2005).
The downward gradient of RA synthesis and Rarb from the
bulge region is consistent with a role for endogenous RA
in outer root sheath differentiation. Crabp2-facilitated RA
signaling may regulate this scattered apoptosis, as Crabp2 has
been implicated in apoptosis regulation in mammary cells
(Donato and Noy, 2005).
Another role of endogenous RA may be to regulate
catagen, as there were several changes in the RA synthesis
and signaling localization pattern during the anagen to
catagen transition. These include a switch in Crabp2
localization from the cells outside the bulge (stem cell niche)
to cells within the bulge (stem cells); a decrease in Rara in
the dermal papilla and connective tissue sheath, except those
outside the bulge (stem cell niche); and an increase in Crbp
and Crabp2 within the lower, regressing, follicle. In addition,
exogenous RA given to anagen hair follicles in culture
induced premature catagen via transforming growth factor
b 2 (Foitzik et al., 2005). The switch in Crabp2 localization
may reduce RA signaling in the stem cell niche, whereas
increasing RA signaling within the stem cells. Transforming
growth factor b 2 may be among the stem cell genes altered
by this switch (Morris et al., 2004; Tumbar et al., 2004).
When exogenous RA is given during anagen, it may disrupt
the balance of RA and binding protein in the bulge stem cells
allowing gene expression to occur in the absence of control
by Crabp2, leading to premature catagen. During anagen,
Rara may act to repress transcription within the connec-
tive tissue sheath (see above). The decrease of Rara in the
connective tissue sheath during anagen VI/catagen I would
remove this inhibition and trigger catagen. In addition to
the reported transforming growth factor b2 involvement,
intracellular adhesion molecule 1 may also be involved.
Intracellular adhesion molecule 1 localization was opposite
that of Rara; it activates catagen, it contains a functional
retinoic acid response element, and RA regulates intracellular
adhesion molecule 1 in normal human epidermal keratino-
cytes in culture (Aoudjit et al., 1995; Janssens et al., 1999;
Muller-Rover et al., 2000). When exogenous RA is given
during anagen, it would disrupt the balance of liganded
to unliganded Rara and activate transcription of RA target
genes such as transforming growth factor b 2 and intracellular
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adhesion molecule 1 to induce premature catagen. Crbp
facilitates the conversion of retinol into both RA and retinyl
esters (Napoli, 1999; Ong, 1994). Both RA and retinyl ester
synthesis may be occurring during catagen, as RA synthesis
enzymes are still present, but have not increased. RA and
Crabp2 may be regulating apoptosis (Donato and Noy, 2005),
whereas the excess retinol is diverted to storage. Later in
catagen, RA synthesis and signaling decreased, which may
inhibit cell growth and limit apoptosis.
As retinoids dose dependently regulate sebocyte prolifera-
tion and lipogenesis, and are one of the major forms of
treatment for acne vulgaris, it was not surprising to see the RA
synthesis and signaling pathway localized there (Zouboulis,
2001, 2004). What is novel is the localization pattern, which
suggests that RA synthesis occurs in the less differentiated
sebocytes, but activation of gene expression in the nucleus
occurs in more differentiated sebocytes where little to no RA
synthesis is occurring. These observations have two implica-
tions. The first implication is that RA regulates sebocyte
proliferation from the more differentiated cells. RA may
regulate proliferation via Indian hedgehog, as Indian hedgehog
expression was changed by altered levels of RA in other tissues
and Indian hedgehog is expressed in differentiated sebocytes
but acts on undifferentiated sebocytes (Yoshida et al., 2001;
Wu et al., 2002; Niemann et al., 2003; Bohnsack et al., 2004).
The second implication of this localization pattern is that
translocation of Crabp2 and Rars to the nucleus is a regulated
process. In cultured cells, Crabp2 translocates to the nucleus
within minutes of RA addition and binding of RA to Crabp2
reveals a nuclear localization signal (Dong et al., 1999;
Budhu and Noy, 2002; Sessler and Noy, 2005). Crabp2 can
also bind Rara, channeling RA from Crabp2 to Rara, and
increase the efficiency of RA-induced transcription (Delva
et al., 1999; Budhu and Noy, 2002; Donato and Noy, 2005).
Our study confirms the nuclear localization of Crabp2 in a
whole animal, but more importantly suggests that in the
whole animal Crabp2 requires more than just RA for nuclear
localization. What keeps Crabp2 and Rars from the nucleus
in less differentiated sebocytes as RA is presumably present?
What then triggers nuclear translocation in differentiated
sebocytes? In the testis, nuclear localization of Rara and
activation of a retinoic acid response element reporter gene
were inhibited by follicle-stimulating hormone, via protein
kinase A, and peroxisome proliferators, and stimulated by
protein kinase C (Dufour and Kim, 1999; Braun et al., 2000,
2002; Dufour et al., 2003). In addition, using green fluores-
cent protein labeling, several other nuclear steroid receptors
were found to shuttle between the nucleus and cytoplasm
(Kawata, 2001). RA and Rars may also act in the cytoplasm
(Everts and Berdanier, 2002; Canon et al., 2004; Rochette-
Egly, 2005). Additional studies are required to determine
what regulates the nuclear localization of Crabp2 and Rars in
the hair follicle and sebaceous gland and what role, if any,
RA and Rars have within the cytoplasm.
Endogenous RA may also regulate epidermal differentiation
and epidermal permeability barrier function. RA regu-
lates several genes in keratinocytes including the differentia-
tion markers transglutaminase, involucrin, filaggrin, keratin 6a,
and keratin 13 (Baron et al., 2005; Rosenthal et al., 1992).
But, in the suprabasal epidermal layer targeted mutations
revealed an essential role for unliganded Rarg/Rxra and
liganded peroxisome proliferators activator-receptor d/Rxra
in lamellar granule regulation and epidermal permeability
barrier function (Calleja et al., 2006). Yet, we saw Rarb in the
cytoplasm throughout the epidermis. As Rarb is upregulated
by RA (Haq et al., 1991), it suggests that active RA signaling
is occurring throughout the epidermis. Studies in cultured
primary keratinocytes also suggest that active RA signaling
may occur in the suprabasal layer with induction of
differentiation (Vettermann et al., 1997; Chatellard-Gruaz
et al., 1998). How could Rarg remain unliganded when RA
synthesis is occurring within this layer? We propose that
Crabp2 binds some of the synthesized RA and directs it to
Rara, whereas the rest of the RA is degraded. Crabp2 directs
RA to Rara and transcriptional activation (Noy, 2000), but
Crabp2 binding to Rarb and Rarg have not yet been tested
and may not occur. During lung development, Rara is
required to maintain Rarb, whereas Rarb regulates fibroblast
growth factor 10 expression and lung morphogenesis (Desai
et al., 2006), suggesting that different Rars regulate different
sets of genes. In addition, the cytochrome p450, family 2,
subfamily S, polypeptide 1 localized throughout the epider-
mis except the cornified layer in human skin, is upregulated
by RA and degrades RA (Smith et al., 2003; Saarikoski et al.,
2005), suggesting that any excess RA not protein-bound in the
epidermis could be degraded. Thus, endogenous RA may
activate Rara-specific genes, like Rarb, whereas Rarg remains
unliganded. The cytoplasmic Rarb may also limit the delivery
of RA to Rarg. Exogenous RA would alter this balance of
Crabp2-directed transcription and activate Rarg target genes
resulting in hyperproliferation and skin fragility.
In summary, this localization pattern suggests that RA
regulates epithelial–mesenchymal interactions in the stem
cell niche and bulb, anagen induction, and differentiation
of all layers of the pilosebaceous unit during anagen. RA
synthesis may occur in less differentiated cells, but signaling
occurs only with differentiation. RA may induce catagen
by reduced unliganded Rara in the connective tissue sheath
and localization of RA signaling within the bulge, as well
as activate apoptosis throughout the regressing follicle. The
localization of endogenous RA synthesis and signaling also
revealed sites where exogenous RA could disrupt the balance
of liganded versus unliganded Rara and Crabp2 leading to
the reported toxic effects including hyperproliferation of the
epidermis, skin fragility, and hair loss. This highlights the
need for a better understanding of endogenous RA function
and the regulation of endogenous RA synthesis, which could
lead to better treatments without unwanted side effects.
Additional functional studies should examine the function of
endogenous RA and the consequences of altered RA synthesis
and signaling in the pilosebaceous unit.
MATERIALS AND METHODS
Tissue acquisition
Twenty-four female C57BL/6J mice were wax stripped to induce
anagen, as described previously (Muller-Rover et al., 2001). Mice
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were anesthetized with 2% tribromoethanol solution (IP, 0.2 ml/10 g;
Sigma-Aldrich, Milwaukee, WI) and all dorsal skin follicles in
telogen, as indicated by pink color, were painted with warm wax
(Surgi-wax; Ardell International, Los Angeles, CA) that was peeled off
after hardening, thus depilating all dorsal skin hair fibers. Skin
samples were harvested from two C57BL/6J wax stripped mice at
each of the following time points: 0, 3, 6, 9, 12, 15, 18, 21, 24, 27,
30, and 32 days after depilation. Skin for both routine histology and
immunohistochemistry (IHC) was fixed overnight in Feketes acid–-
alcohol–formalin solution (61% ethanol, 3.2% formaldehyde, 0.75 N
acetic acid), transferred to 70% ethanol, processed routinely,
embedded in paraffin, sectioned at 5–6 mm, placed on microscope
slides (Superfrost/Plus Fisherbrand, Pittsburgh, PA) and stained with
hematoxylin and eosin for routine histopathologic analysis. All
mouse studies were approved by The Jackson Laboratory Institu-
tional Animal Care and Use Committee and were performed in
compliance with stipulations of that body.
Antibodies
All rabbit studies were approved by The Vanderbilt University
Medical Center Institutional Animal Care and Use Committee and
were performed in compliance with stipulations of that body.
Antibodies against Crbp, eRoldh/Dhrs9, Aldh1a2, and Aldh1a3
were all produced within our laboratory and their specificity was
established previously (Zheng and Ong, 1998; Rexer and Ong, 2002;
Everts et al., 2004). The antibody used against Aldh1a3 in this study
was from a different rabbit raised at the same time as the antibody
described previously (Everts et al., 2004). This antibody proved to
be more sensitive for IHC, whereas the specificity based on dot-blot
analysis against bacterially expressed proteins was the same.
Antibodies raised against different epitopes of eRoldh/Dhrs9 and
Crabp2 were examined and produced similar results. The first of
these two antibodies has been described previously (Wardlaw et al.,
1997; Rexer and Ong, 2002). The second antibody raised against a
different epitope of Crabp2 was produced as described previously
(Everts et al., 2004) using the peptide CEQRLLKGEGPKTS from the
rat sequence. Two additional antibodies raised against different
epitopes of eRoldh/Dhrs9 were produced as described previously
(Rexer and Ong, 2002) using the peptide CGFLWTRKGKLKIED from
the human sequence and DPIKTTEKKLA from the rat sequence.
Specificity of the antibodies against Crbp, eRoldh/Dhrs9, Aldh1a2,
Aldh1a3, and Crabp2 were also confirmed by obtaining similar
localization patterns between IHC, Western blot analysis, and
reverse transcription-PCR in sites that have been previously shown
to be sensitive to dietary vitamin A (Everts et al., 2005). In that study,
we also found eRoldh/Dhrs9 and Crabp2 to be negative in rat
liver and kidney by all three methods. The Aldh1a1 antibody was
also produced as described previously (Everts et al., 2004) using the
peptide CGGGRWGNKGFFVQP from the rat sequence. Protein
levels of Aldh1a1 (Raldh1) by both Western blots analysis and IHC
are greater in the uterus with this antibody during diestrus than estrus
(unpublished observation), which is the same localization pattern as
we reported for the mRNA (Li et al., 2004). Specificity for antibodies
against Crbp, eRoldh/Dhrs9, Aldh1a1-3, and Crabp2 was also
confirmed by running IHC with equivalent amounts of IgG
(determined by absorption at 280 nm) from the IgG flow through
from the respective affinity columns. Except for the antibody against
eRoldh/Dhrs9 (whose specificity was confirmed by several other
methods, see above) there was no IR seen in sites where the affinity-
purified antibody was seen, and some IgG fractions were completely
negative (data not shown). Antibodies against Rara, b, and g were
purchased from Santa Cruz Biotech (Santa Cruz, CA). To confirm
their specificity, these antibodies were preabsorbed for 2 hours at
room temperature with five times their respective blocking peptide
(Santa Cruz Biotech). The expression seen for both Rara and Rarb
was completely lost in the control that was preabsorbed with
blocking peptide. But there was still some background signal seen
after preabsorption with the Rarg antibody. This background signal
was subtracted from the signal seen without the peptide to determine
the expression level of Rarg, although some sites were not scorable
with the Rarg antibody because of this background. Controls that
used just blocking solution (no primary antibody) were also run.
Occasionally background signal was seen in sebaceous glands in the
no primary control sections.
IHC
Sections were pretreated with 3% hydrogen peroxide, blocked with
3% BSA plus 1.28% normal goat serum, incubated with affinity-
purified rabbit polyclonal antibodies against Crbp, eRoldh/Dhrs9,
Aldh1a1, 2, or 3, Crabp2, Rara, b, or g (described above) overnight
at 41C. Tissue was then incubated with a biotin-conjugated
secondary antibody, an anti-biotin IgG-conjugated with horseradish
peroxidase, and then stained with AECþ (Dako, Carpinteria, CA;
Bucco et al., 1997). Hydrogen peroxide and BSA were obtained from
Sigma . Normal goat serum, secondary, and tertiary antibodies were
obtained from Jackson ImmunoResearch Laboratories, Inc. (West
Grove, PA). Hair follicles were classified by stage (Muller-Rover
et al., 2001) and IR scored on a scale of 0–4, blinded by the
knowledge of days after depilation. For most stages, three to nine
hair follicles were scored per stage. During anagen VI/catagen I and
late catagen through early anagen, 11–24 hair follicles were scored
per stage, but only one or two follicles in catagen II and III were seen
and scored. Mean and SD was performed to highlight variability, but
no statistics were run as this study was intended to point out
qualitative localization patterns.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by grants from the National Institutes of Health
(DK32642, AR041943, AR052009, and AR052710), the Wauford Foundation
and the North American Hair Research Society. We thank Ingrid Sundberg
(www.sundbergstudio.com) for drawing the illustration in Figure 4 and
Kathleen Silva for all of the work with the mice. The mouse genome
nomenclature was used throughout, except Crbp (current mouse name Rbp1;
www.informatics.jax.org). Genes and RNA message expression is italicized,
whereas proteins are not. First letter capitalized followed by lowercase
indicates a mouse or rat gene, whereas all capital letters indicates the human
gene or protein.
SUPPLEMENTARY MATERIAL
Table S1. Immunolocalization of RA biosynthesis and signaling primarily with
Aldh1a2.
Table S2. Immunolocalization of RA biosynthesis and signaling with primarily
Aldh1a3.
Table S3. Immunolocalization of RA biosynthesis and signaling using various
retinal dehydrogenases.
www.jidonline.org 1601
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
REFERENCES
Abu-Abed S, MacLean G, Fraulob V, Chambon P, Petkovich M, Dolle P
(2002) Differential expression of the retinoic acid-metabolizing enzymes
Cyp26a1 and Cyp26b1 during murine organogenesis. Mech Dev
110:173–7
Alonso L, Fuchs E (2003) Stem cells in the skin: waste not, Wnt not. Genes
Dev 17:1189–200
Aoudjit F, Brochu N, Morin N, Poulin G, Stratowa C, Audette M (1995)
Heterodimeric retinoic acid receptor-beta and retinoid-X receptor-alpha
complexes stimulate expression of the intercellular-adhesion molecule-1
gene. Cell Growth Differ 6:515–21
Balmer JE, Blomhoff R (2002) Gene expression regulation by retinoic acid.
J Lipid Res 43:1773–808
Baron JM, Heise R, Blaner WS, Neis M, Joussen S, Dreuw A et al. (2005)
Retinoic acid and its 4-oxo metabolites are functionally active in human
skin cells in vitro. J Invest Dermatol 125:143–53
Bavik C, Ward SJ, Ong DE (1997) Identification of a mechanism to localize
generation of retinoic acid in rat embryos. Mech Dev 69:155–67
Billoni N, Gautier B, Mahe YF, Bernard BA (1997) Expression of retinoid
nuclear receptor superfamily members in human hair follicles and its
implication in hair growth. Acta Dermato-Venereologica 77:350–5
Blentic A, Gale E, Maden M (2003) Retinoic acid signalling centres in the
avian embryo identified by sites of expression of synthesizing and
catabolising enzymes. Dev Dyn 227:114–27
Bohnsack BL, Lai LH, Dolle P, Hirschi KK (2004) Signaling hierarchy
downstream of retinoic acid that independently regulates vascular
remodeling and endothelial cell proliferation. Genes Dev 18:1345–58
Botchkarev VA, Botchkareva NV, Nakamura M, Huber O, Funa K, Lauster R
et al. (2001) Noggin is required for induction of the hair follicle growth
phase in postnatal skin. FASEB J 15:2205–14
Botchkarev VA, Kishimoto J (2003) Molecular control of epithelial-mesench-
ymal interactions during hair follicle cycling. J Investig Dermatol Symp
Proc 8:46–55
Boylan JF, Gudas LJ (1992) The level of Crabp-I expression influences the
amounts and types of all-trans-retinoic acid metabolites in F9 terato-
carcinoma stem-cells. J Biol Chem 267:21486–91
Braun KW, Tribley WA, Griswold MD, Kim KH (2000) Follicle-stimulating
hormone inhibits all-trans-retinoic acid-induced retinoic acid receptor
alpha nuclear localization and transcriptional activation in mouse Sertoli
cell lines. J Biol Chem 275:4145–51
Braun KW, Vo MN, Kim KH (2002) Positive regulation of retinoic acid
receptor alpha by protein kinase C and mitogen-activated protein kinase
in sertoli cells. Biol Reprod 67:29–37
Bucco RA, Zheng WL, Davis JT, Sierra-Rivera E, Osteen KG, Chaudhary AK
et al. (1997) Cellular retinoic acid-binding protein (II) presence in rat
uterine epithelial cells correlates with their synthesis of retinoic acid.
Biochemistry 36:4009–14
Budhu AS, Noy N (2002) Direct channeling of retinoic acid between cellular
retinoic acid-binding protein II and retinoic acid receptor sensitizes
mammary carcinoma cells to retinoic acid-induced growth arrest. Mol
Cell Biol 22:2632–41
Calleja C, Messaddeq N, Chapellier B, Yang HY, Krezel W, Li M et al. (2006)
Genetic and pharmacological evidence that a retinoic acid cannot be the
RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev
20:1525–38
Canon E, Cosgaya JM, Scsucova S, Aranda A (2004) Rapid effects of retinoic
acid on CREB and ERK phosphorylation in neuronal cells. Mol Biol Cell
15:5583–92
Chatellard-Gruaz D, Randolph RK, Hagens G, Saurat JH, Siegenthaler G
(1998) Differentiation of human epidermal keratinocytes is accompanied
by increased expression of CRABP-II and increased cellular concentra-
tion of retinoic acids: retention of newly synthesized retinoic acids by
CRABP-II. J Lipid Res 39:1421–9
Chen AC, Yu K, Lane MA, Gudas LJ (2003) Homozygous deletion of the
CRABPI gene in AB1 embryonic stem cells results in increased CRABPII
gene expression and decreased intracellular retinoic acid concentration.
Arch Biochem Biophys 411:159–73
Chetyrkin SV, Belyaeva OV, Gough MH, Kedishvili NY (2001) Characteriza-
tion of a novel type of human microsomal 3 alpha-hydroxysteroid
dehydrogenase - Unique tissue distribution and catalytic properties.
J Biol Chem 276:22278–86
Cotsarelis G (2006) Epithelial stem cells: A folliculocentric view. J Invest
Dermatol 126:1459–68
DasGupta R, Rhee H, Fuchs E (2002) A developmental conundrum: a
stabilized form of beta-catenin lacking the transcriptional activation
domain triggers features of hair cell fate in epidermal cells and epidermal
cell fate in hair follicle cells. J Cell Biol 158:331–44
Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G et al.
(1999) Physical and functional interactions between cellular retinoic
acid binding protein II and the retinoic acid-dependent nuclear complex.
Mol Cell Biol 19:7158–67
Desai TJ, Chen F, Lu JM, Qian J, Niederreither K, Dolle P et al. (2006) Distinct
roles for retinoic acid receptors alpha and beta in early lung
morphogenesis. Dev Biol 291:12–24
Donato LJ, Noy N (2005) Suppression of mammary carcinoma growth by
retinoic acid: Proapoptotic genes are targets for retinoic acid receptor
and cellular retinoic acid-binding protein II signaling. Cancer Res
65:8193–9
Dong D, Ruuska SE, Levinthal DJ, Noy N (1999) Distinct roles for cellular
retinoic acid-binding proteins I and II in regulating signaling by retinoic
acid. J Biol Chem 274:23695–8
Dufour JM, Kim KH (1999) Cellular and subcellular localization of six retinoid
receptors in rat testis during postnatal development: Identification of
potential heterodimeric receptors. Biol Reprod 61:1300–8
Dufour JM, Vo MN, Bhattacharya N, Okita J, Okita R, Kim KH (2003)
Peroxisorne proliferators disrupt retinoic acid receptor alpha signaling in
the testis. Biol Reprod 68:1215–24
Dupe V, Matt N, Garnier JM, Chambon P, Mark M, Ghyselinck NB (2003)
A newborn lethal defect due to inactivation of retinaldehyde dehydro-
genase type 3 is prevented by maternal retinoic acid treatment. Proc Natl
Acad Sci USA 100:14036–41
Everts HB, Berdanier CD (2002) Regulation of mitochondrial gene expression
by retinoids. IUBMB Life 54:45–9
Everts HB, King LE Jr, Sundberg JP, Ong DE (2004) Hair cycle-specific
immunolocalization of retinoic acid synthesizing enzymes Aldh1a2 and
Aldh1a3 indicate complex regulation. J Invest Dermatol 123:258–63
Everts HB, Sundberg JP, Ong DE (2005) Immunolocalization of retinoic acid
biosynthesis systems in selected sites in rat. Exp Cell Res 308:309–19
Fan X, Molotkov A, Manabe S, Donmoyer CM, Deltour L, Foglio MH et al.
(2003) Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a
complex mechanism of retinoic acid synthesis in the developing retina.
Mol Cell Biol 23:4637–48
Foitzik K, Spexard T, Nakamura M, Halsner U, Paus R (2005) Towards
dissecting the pathogenesis of retinoid-induced hair loss: All-trans
retinoic acid induces premature hair follicle regression (catagen) by
upregulation of transforming growth factor-beta 2 in the dermal papilla.
J Invest Dermatol 124:1119–26
Frazier CN, Hu C-K (1931) Cutaneous lesions associated with a deficiency in
vitamin A in man. Arch. Intern. Med. 48:507–14
Haq R, Pfahl M, Chytil F (1991) Retinoic acid affects the expression of nuclear
retinoic acid receptors in tissues of retinol-deficient rats. Proc Natl Acad
Sci USA 88:8272–6
Janssens S, Bols L, Vandermeeren M, Daneels G, Borgers M, Geysen J (1999)
Retinoic acid potentiates TNF-alpha-induced ICAM-1 expression in
normal human epidermal keratinocytes. Biochem Biophys Res Com
255:64–9
Kawata M (2001) Subcellular steroid/nuclear receptor dynamics. Arch Histol
Cytol 64:353–68
Langbein L, Schweizer J (2005) Keratins of the human hair follicle. Int Rev
Cytol 243:1–78
1602 Journal of Investigative Dermatology (2007), Volume 127
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
Legue E, Nicolas JF (2005) Hair follicle renewal: organization of stem cells in
the matrix and the role of stereotyped lineages and behaviors.
Development 132:4143–54
Li XF, Schwarz EM, Zuscik MJ, Rosier RN, Ionescu AM, Puzas JE et al. (2003)
Retinoic acid stimulates chondrocyte differentiation and enhances bone
morphogenetic protein effects through induction of Smad1 and Smad5.
Endocrinology 144:2514–23
Li XH, Kakkad B, Ong DE (2004) Estrogen directly induces expression of
retinoic acid biosynthetic enzymes, compartmentalized between the
epithelium and underlying stromal cells in rat uterus. Endocrinology
145:4756–62
Lin KK, Chudova D, Hatfield GW, Smyth P, Andersen B (2004) Identification
of hair cycle-associated genes from time-course gene expression profile
data by using replicate variance. Proc Natl Acad Sci USA 101:15955–60
Lo Celso C, Prowse DM, Watt FM (2004) Transient activation of beta-catenin
signalling in adult mouse epidermis is sufficient to induce new hair
follicles but continuous activation is required to maintain hair follicle
tumours. Development 131:1787–99
Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, Fuchs E (2005)
Defining the impact of beta-catenin/Tcf transactivation on epithelial
stem cells. Genes Dev 19:1596–611
Markova NG, Pinkas-Sarafova A, Karaman-Jurukovska N, Jurukovski V,
Simon M (2003) Expression pattern and biochemical characteristics of
a major epidermal retinol dehydrogenase. Mol Genet Metabolism 78:
119–35
Merrill BJ, Gat U, DasGupta R, Fuchs E (2001) Tcf3 and Lef1 regulate
lineage differentiation of multipotent stem cells in skin. Genes Dev 15:
1688–705
Millar SE, Willert K, Salinas PC, Roelink H, Nusse R, Sussman DJ et al. (1999)
WNT signaling in the control of hair growth and structure. Dev Biol
207:133–49
Molotkov A, Duester G (2003) Genetic evidence that retinaldehyde
dehydrogenase Raldh1 (Aldh1a1) functions downstream of alcohol
dehydrogenase Adh1 in metabolism of retinol to retinoic acid. J Biol
Chem 278:36085–90
Molotkov A, Molotkova N, Duester G (2006) Retinoic acid guides eye
morphogenetic movements via paracrine signaling but is unnecessary for
retinal dorsoventral patterning. Development 133:1901–10
Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S et al. (2004) Capturing and
profiling adult hair follicle stem cells. Nat Biotechnol 22:411–7
Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC (2005) Interaction of
nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you
like to know? Endocrine Rev 26:898–915
Muller-Rover S, Bulfone-Paus S, Handjiski B, Welker P, Sundberg JP, McKay
IA et al. (2000) Intercellular adhesion molecule-1 and hair follicle
regression. J Histochem Cytochem 48:557–68
Muller-Rover S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay
IA et al. (2001) A comprehensive guide for the accurate classification of
murine hair follicles in distinct hair cycle stages. J Invest Dermatol 117:
3–15
Napoli JL (1999) Interactions of retinoid binding proteins and enzymes in
retinoid metabolism. Biochim Biophys Acta 1440:139–62
Niederreither K, Fraulob V, Garnier JM, Chambon P, Dolle P (2002)
Differential expression of retinoic acid-synthesizing (Raldh) enzymes
during fetal development and organ differentiation in the mouse. Mech
Dev 110:165–71
Niederreither K, Subbarayan V, Dolle P, Chambon P (1999) Embryonic
retinoic acid synthesis is essential for early mouse post-implantation
development. Nat Genet 21:444–8
Niemann C, Unden AB, Lyle S, Zouboulis Ch C, Toftgard R, Watt FM (2003)
Indian hedgehog and beta-catenin signaling: role in the sebaceous
lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad
Sci USA 100:11873–80
Noy N (2000) Retinoid-binding proteins: mediators of retinoid action.
Biochem J 348:481–95
Ong DE (1994) Cellular transport and metabolism of vitamin A: roles of the
cellular retinoid-binding proteins. Nutr Rev 52:S24–31
Ong DE, MacDonald PN, Gubitosi AM (1988) Esterification of retinol in rat
liver. Possible participation by cellular retinol-binding protein and
cellular retinol-binding protein II. J Biol Chem 263:5789–96
Oro AE, Higgins K (2003) Hair cycle regulation of hedgehog signal reception.
Dev Biol 255:238–48
Paus R, Foitzik K (2004) In search of the "hair cycle clock": a guided tour.
Differentiation 72:489–511
Privalsky ML (2004) The role of corepressors in transcriptional regulation by
nuclear hormone receptors. Annu Rev Physiol 66:315–60
Reddy S, Andl T, Bagasra A, Lu MM, Epstein DJ, Morrisey EE et al. (2001)
Characterization of Wnt gene expression in developing and postnatal
hair follicles and identification of Wnt5a as a target of Sonic hedgehog in
hair follicle morphogenesis. Mech Dev 107:69–82
Reddy ST, Andl T, Lu MM, Morrisey EE, Millar SE (2004) Expression of
Frizzled genes in developing and postnatal hair follicles. J Invest
Dermatol 123:275–82
Reichrath J, Mittmann M, Kamradt J, Muller SM (1997) Expression of retinoid-
X receptors (-alpha, -beta, -gamma) and retinoic acid receptors (-alpha,
-beta, -gamma) in normal human skin: an immunohistological evalua-
tion. Histochem J 29:127–33
Rexer BN, Ong DE (2002) A novel short-chain alcohol dehydrogenase from
rats with retinol dehydrogenase activity, cyclically expressed in uterine
epithelium. Biol Reprod 67:1555–64
Rochette-Egly C (2005) Dynamic combinatorial networks in nuclear receptor-
mediated transcription. J Biol Chem 280:32565–8
Rosenthal DS, Griffiths CEM, Yuspa SH, Roop DR, Voorhees JJ (1992) Acute
or chronic topical retinoic acid treatment of human skin in vivo alters the
expression of epidermal transglutaminase, loricrin, involucrin, filaggrin,
and keratin-6 and keratin-13 but not keratin-1, keratin-10, and keratin-
14. J Invest Dermatol 98:343–50
Saarikoski ST, Wikman HAL, Smith G, Wolff CHJ, Husgafvel-Pursiainen K
(2005) Localization of cytochrome P450CYP2S1 expression in human
tissues by in situ hybridization and immunohistochemistry. J Histochem
Cytochem 53:549–56
Schlake T (2005) FGF signals specifically regulate the structure of hair shaft
medulla via IGF-binding protein 5. Development 132:2981–90
Sessler RJ, Noy N (2005) A ligand-activated nuclear localization signal in
cellular retinoic acid binding protein-II. Mol Cell 18:343–53
Shibamoto S, Winer J, Williams M, Polakis P (2004) A blockade in Wnt
signaling is activated following the differentiation of F9 teratocarcinoma
cells. Exp Cell Res 292:11–20
Shimizu H, Morgan BA (2004) Wnt signaling through the beta-catenin
pathway is sufficient to maintain, but not restore, anagen-phase
characteristics of dermal papilla cells. J Invest Dermatol 122:239–45
Siegenthaler G, Saurat JH, Morin C, Hotz R (1984) Cellular retinol-binding
and retinoic acid-binding proteins in the epidermis and dermis of normal
human-skin. Br J Dermatol 111:647–54
Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM et al. (2003)
Cutaneous expression of cytochrome P450 CYP2S1: individuality in
regulation by therapeutic agents for psoriasis and other skin diseases.
Lancet 361:1336–43
Smyth I, Ellis T, Hetherington R, Riley E, Narang M, Mahony D et al. (2004)
Krt6a-cre transgenic mice direct loxP-mediated recombination to the
companion cell layer of the hair follicle and following induction by
retinoic acid to the interfollicular epidermis. J Invest Dermatol 122:232–4
Soref CM, Di YP, Hayden L, Zhao YH, Satre MA, Wu R (2001)
Characterization of a novel airway epithelial cell-specific short chain
alcohol dehydrogenase/reductase gene whose expression is up-regulated
by retinoids and is involved in the metabolism of retinol. J Biol Chem
276:24194–202
Stenn KS, Paus R (2001) Controls of hair follicle cycling. Physiol Rev 81:
449–94
Thody AJ, Shuster S (1989) Control and Function of Sebaceous Glands.
Physiol Rev 69:383–416
www.jidonline.org 1603
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
Tobin DJ, Gunin A, Magerl M, Handijski B, Paus R (2003) Plasticity and
cytokinetic dynamics of the hair follicle mesenchyme: implications for
hair growth control. J Invest Dermatol 120:895–904
Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M et al.
(2004) Defining the epithelial stem cell niche in skin. Science 303:
359–63
Van Mater D, Kolligs FT, Dlugosz AA, Fearon ER (2003) Transient activation
of beta -catenin signaling in cutaneous keratinocytes is sufficient to
trigger the active growth phase of the hair cycle in mice. Genes Dev
17:1219–24
Vettermann O, Siegenthaler G, Winter H, Schweizer J (1997) Retinoic acid
signaling cascade in differentiating murine epidermal keratinocytes:
Alterations in papilloma- and carcinoma-derived cell lines. Mol
Carcinog 20:58–67
Wardlaw SA, Bucco RA, Zheng WL, Ong DE (1997) Variable expression
of cellular retinol- and cellular retinoic acid-binding proteins in
the rat uterus and ovary during the estrous cycle. Biol Reprod 56:
125–132
Wolbach SB, Howe PR (1925) Tissue changes following deprivation of
fat-soluble A vitamin. J Exp Med 42:753–77
Wu LN, Lu M, Genge BR, Guo GY, Nie D, Wuthier RE (2002) Discovery of
sonic hedgehog expression in postnatal growth plate chondrocytes:
differential regulation of sonic and Indian hedgehog by retinoic acid.
J Cell Biochem 87:173–87
Yoshida E, Noshiro M, Kawamoto T, Tsutsumi S, Kuruta Y, Kato Y
(2001) Direct inhibition of Indian hedgehog expression by parathyroid
hormone (PTH)/PTH-related peptide and up-regulation by retinoic acid
in growth plate chondrocyte cultures. Exp Cell Res 265:64–72
Zheng WL, Ong DE (1998) Spatial and temporal patterns of expression of
cellular retinol-binding protein and cellular retinoic acid-binding
proteins in rat uterus during early pregnancy. Biol Reprod 58:963–70
Zhuang Y, Faria TN, Chambon P, Gudas LJ (2003) Identification and
characterization of retinoic acid receptor beta2 target genes in F9
teratocarcinoma cells. Mol Cancer Res 1:619–30
Zouboulis CC (2001) Retinoids – which dermatological indications will
benefit in the near future? Skin Pharmacol Appl Skin Physiol 14:303–15
Zouboulis CC (2004) Acne and sebaceous gland function. Clin Dermatol
22:360–6
1604 Journal of Investigative Dermatology (2007), Volume 127
HB Everts et al.
IHC of RA Synthesis/Signaling in Hair Cycle
